Clinical Trial

Supplementation for Male Subfertility

Study acronym: FertEnhancer
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated October 10, 2024 (before its estimated February 2, 2026 completion). Its status may not reflect the trial's current state.
Summary
Old age, obesity, physical inactivity, environmental factors and genetics may contribute negatively to fertility in both males and females. In males, specifically, certain supplements, such as single antioxidants and trace minerals, have previously been shown to improve sperm function marginally. One hypothesis is that sperm function can be improved even further by combining several different types of supplements (e.g., amino acids, energy carriers, vitamins, antioxidants, and trace minerals) to target several age-related cell pathways, for example, oxidative stress, mitochondrial dysfunction, inflammation and cell energetics. This 3-month placebo-controlled, randomized clinical trial, aims to test the effects of a novel multi-ingredient supplement (Fertility Enhancer) that targets several age-related cell pathways on sperm function in overweight or obese and subfertile males.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-16; most recent amendment 2024-10-08.
Trial Details
NCT Number NCT06091969
Lead Sponsor Hamilton Health Sciences Corporation
Collaborators: One Fertility
Conditions Male Infertility
Enrollment 64 participants
Start Date 2025-01-01
Primary Completion 2026-02-02 (estimated)
Study Completion 2026-02-02 (estimated)
Updated on ClinicalTrials.gov 2024-10-10